Dr. Katrina S Pedersen MD
Oncologist | Medical Oncology
200 1st St SW Rochester MN, 55905About
Dr. Katrina Pedersen is an oncologist practicing in Rochester, MN. Dr. Pedersen specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Pedersen manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Southern Illinois University At Edwardsville 2009
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Effects of inbreeding and rate of inbreeding in Drosophila melanogaster- Hsp70 expression and fitness.
- A test of quantitative genetic theory using Drosophila- effects of inbreeding and rate of inbreeding on heritabilities and variance components.
- Limitations in the use of Drosophila melanogaster as a model host for gram-positive bacterial infection.
- Proteomic characterization of a temperature-sensitive conditional lethal in Drosophila melanogaster.
- Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.
- Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls.
- BRCA2-associated pancreatic cancer and current screening guidelines.
- Report of mecC-carrying MRSA in domestic swine.
- Comparison of bacterial culture and qPCR testing of rectal and pen floor samples as diagnostic approaches to detect enterotoxic Escherichia coli in nursery pigs.
Clinical Trials
- Epacadostat (INCB024360) and Pembrolizumab Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors
- Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
- Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer
Dr. Katrina S Pedersen MD's Practice location
Dr. Katrina S Pedersen MD's reviews
Write ReviewPatient Experience with Dr. Pedersen
Recommended Articles
- Is Leukemia Fatal?
Leukemia is a malignancy, or cancer, of the blood and bone marrow that primarily affects the white blood cells — the blood cells responsible for fighting off infections and other foreign organisms that enter the bloodstream. With leukemia, the bone marrow produces a higher level of immature white...
- What Are the Signs and Symptoms of Liver Cancer?
Liver cancer is a condition that is characterized by the abnormal or cancerous growth of liver cells. Liver cells are also called as hepatocytes. Hence, liver cancer can also be called as hepatocellular cancer. Although other cell types can become cancerous, the most common cause of liver cancer is...
- Are There Routine Checks for Ovarian Cancer?
Ovarian cancer is the most common cause of death among gynecologic types of cancer. The most common risk factors for ovarian cancer are:...
- What is Cancer Immunotherapy?
Immunotherapy, also referred as biological therapy, is a special type of cancer treatment aimed at boosting the body's immune system to help fight cancer cells. Cancer cells don’t die normally as other cells do, and divide uncontrollably with each cell making more of itself like a copy machine...
- Is a Mastectomy an Efficient Option to Treat Breast Cancer?
A mastectomy refers to the surgery performed to remove the breasts, either completely or partially. This was one of the traditional methods in the treatment of breast cancer for a long time. It is also used as a method to reduce the chances of developing breast cancer for women who have a high risk...
- Can Bisphosphonates Stop Breast Cancer from Spreading to Bones?
Two years ago, at the age of 44, Susan Leonard was diagnosed with stage II breast cancer – a disease that affects over 260,000 American women on an annual basis. In order to keep her cancer from recurring, she had to undergo countless treatments, including chemotherapy, hormone therapy, a double...
Nearby Providers
- Thomas Habermann2123 Valkyrie Court Northwest Rochester Minnesota 55901
- Dr. Tufia Christine Haddad MD200 1st St SW Rochester MN 55905
- Dr. Edward T. Creagan M.D.200 1st St SW Rochester MN 55905
- Dr. Judith S Kaur MD200 1st St SW Rochester MN 55905
- Dr. Matthew S Block MD, PHD200 1st St SW Rochester MN 55905
- Mateusz Opyrchal MD PHD200 1st St SW Rochester MN 55905